AI-CVD vs Clarius AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung Corporation
VS
by Clarius Mobile Health

AI Verdict

AI-CVD and Clarius AI are adjacent competitors, both leveraging AI in cardiology but with distinct imaging modalities and applications. AI-CVD focuses on opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, providing comprehensive risk stratification beyond just coronary artery calcium scoring. Clarius AI, on the other hand, integrates AI into handheld ultrasound scanners to enhance real-time image quality, automate measurements, and provide guidance across various specialties, including cardiology, at the point of care.

Choose AI-CVD if…

Choose AI-CVD if your institution primarily utilizes existing CT scans for opportunistic screening and early detection of a broad range of cardiovascular and multisystem diseases. This tool is ideal for identifying hidden health risks like coronary artery calcium, aortic calcification, cardiac chamber volumetry, and even bone mineral density and liver fat, without requiring additional imaging or disrupting current workflows.

View AI-CVD →

Choose Clarius AI if…

Choose Clarius AI if your clinical setting requires highly portable, real-time ultrasound imaging with AI-powered assistance for various specialties, including emergency medicine, obstetrics/gynecology, and cardiology. This tool is best suited for enhancing image quality, automating measurements (e.g., fetal biometrics, ejection fraction), and providing real-time guidance, especially for point-of-care ultrasound applications and in environments where traditional cart-based systems are impractical.

View Clarius AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD Clarius AI
Pricing Contact for pricing Subscription-based with scanner purchase or one-time purchase with add-ons.
Deployment Cloud Cloud-based (Clarius Cloud) and mobile application (iOS/Android).
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Clarius AI

Clarius AI appears to have a stronger focus on user experience, offering features like Auto Preset AI for automatic image optimization, real-time AI labeling and anatomical overlays for guidance, and voice controls for hands-free operation. These features are designed to make ultrasound easier to use, even for novice users, and streamline workflows. While AI-CVD aims to integrate into existing CT scan workflows without disruption, its primary focus is on automated measurements rather than interactive user guidance during image acquisition.

Clinical Value

Clarius AI

Both tools demonstrate significant clinical value. AI-CVD offers opportunistic screening for a wide range of cardiovascular and multisystem diseases from existing CT scans, providing comprehensive measurements for risk stratification. Clarius AI, however, integrates directly into handheld ultrasound scanners, offering real-time AI-powered enhancements for image quality, automated measurements, and guidance across various specialties including cardiology, OB/GYN, and radiology. This real-time, point-of-care application, coupled with its broader range of specialties and FDA clearances for specific AI models like Ejection Fraction AI and OB AI, suggests a more immediate and diverse clinical impact.

Pricing & Value

Clarius AI

Clarius AI offers transparent, subscription-based pricing with clear details on scanner purchases and annual memberships, which unlock advanced software, AI tools, and cloud storage. This upfront pricing model allows potential users to understand the investment. AI-CVD's pricing is listed as 'contact for pricing,' which, while common for enterprise solutions, lacks transparency for initial evaluation. The affordability and accessibility of Clarius's handheld ultrasound systems, combined with its membership benefits, suggest a stronger value proposition for a wider range of medical professionals.

Enterprise Readiness

Tie

Both tools demonstrate aspects of enterprise readiness. AI-CVD is designed for integration into existing CT scan workflows and offers opportunistic screening on a large scale, implying suitability for hospital systems. Clarius AI has recently introduced enterprise software solutions to manage fleets of scanners for large healthcare institutions, along with HIPAA compliance and BAA availability. Without more specific details on API integrations, scalability for diverse IT environments, and existing enterprise deployments for AI-CVD, it's difficult to definitively pick a winner.

Innovation

Clarius AI

Clarius AI demonstrates a higher degree of innovation through its integration of AI directly into handheld, portable ultrasound devices, enabling real-time guidance, automated measurements, and image optimization at the point of care. This approach makes advanced ultrasound capabilities more accessible and easier to use. While AI-CVD's opportunistic screening from existing CT scans is innovative in leveraging existing data for early detection, Clarius AI's continuous development of new AI models and features for a portable platform shows a more dynamic and disruptive innovation in the medical imaging space.

Support & Docs

Clarius AI

Clarius AI explicitly mentions an 'Education Portal' and 'Clarius Education' as part of its membership, offering resources to accelerate proficiency and master ultrasound scanning. They also host clinical webinars and have an education partner network. AI-CVD's documentation and support offerings are not detailed in the provided information, making it difficult to assess. The emphasis on education and ongoing support from Clarius suggests a more robust and transparent approach to user enablement.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD Clarius AI
Tool Name AI-CVD Clarius AI
Company HeartLung Corporation Clarius Mobile Health
Description FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. Suite of artificial intelligence features integrated into Clarius Mobile Health's handheld ultrasound scanners and app, designed to enhance image quality, automate measurements, and provide real-time guidance for clinicians across various specialties.
Primary Imaging Modality CT scans Handheld ultrasound scanners
Key Features (Examples) Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, Coronary Artery Calcium (CAC) scoring Auto Preset AI for automatic image optimization and anatomy detection, Real-time AI labeling and anatomical overlays (T-Modeu2122) for training and guidance, Semi-automatic measurements for various structures

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Clarius AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVD is designed for opportunistic screening using existing CT scans, implying it integrates by analyzing readily available imaging data without disrupting current CT acquisition workflows. Clarius AI, integrated into handheld ultrasound scanners and an app, offers features like automated measurements, integrated patient reports, and CPT medical codes, which can streamline documentation and billing within a physician's workflow.
AI-CVD has shown high predictive performance for cardiac events, with studies indicating AUC values between 0.84 and 0.92, and sensitivity and specificity higher than traditional risk scores. Clarius AI's Ejection Fraction AI tool, for example, automates LVEF calculation to remove subjectivity and accelerate diagnosis, and its OB AI model has demonstrated accuracy in fetal biometric measurements.
Clarius AI aims to accelerate the learning curve for ultrasound with features like T-Mode AI, which uses color-coded anatomical overlays and labels to help new users interpret images in real-time. While AI-CVD leverages existing CT scans, the learning curve would likely involve understanding and incorporating the new quantitative measurements into clinical decision-making, potentially aided by AI's ability to accelerate the learning process for physicians by capturing expert knowledge through big data.
Clarius offers a membership that unlocks advanced software, AI tools, unlimited cloud storage, real-time telemedicine, DICOM/PACS integration, and access to the Clarius Education Portal. For AI-CVD, the information provided does not detail specific customer support offerings, but generally, successful AI integration requires understanding human factors and designing workflows that fit clinical practice.
AI-CVD offers opportunistic screening from existing CT scans, potentially enabling early detection of hidden health risks without additional imaging or workflow disruption, which could lead to earlier interventions and improved patient outcomes. Clarius AI streamlines workflows with features like automated measurements, integrated patient reports, and CPT codes, which can save time on documentation and billing, allowing physicians to see more patients.
The provided information does not explicitly detail audit-trail features for either AI-CVD or Clarius AI. However, generally, labeling AI-generated results clearly and providing physicians with data for individual assessment, along with flagging cases for additional review, can help mitigate potential errors from automated reads.
AI Tool Finder
AI-powered search. Results may not be comprehensive.